
ESTA Stock Forecast & Price Target
ESTA Analyst Ratings
Bulls say
Establishment Labs Hldgs is a medical technology company that designs, manufactures, and markets silicone-filled breast and body-shaping implants. Its revenue growth, driven by strong sales in the U.S. and progress towards profitability, is expected to reach $35M this year. The company has surpassed 1,700 U.S. accounts and is seeing a shift in behavior among higher-volume surgeons, resulting in a 30% increase in average orders. With its unique product and potential for expansion into new markets, this company has strong potential for long-term success.
Bears say
Establishment Labs Hldgs is expected to have a strong revenue growth trajectory, with guidance for the full year 2026 forecasted to increase by 26-27% year-over-year and US revenue expected to exceed 30% of overall sales. However, the company's reliance on a single product, Motiva implants, and its high valuation compared to industry peers may pose risks for potential investors. Additionally, the company's positive outlook for free cash flow in 2026 may be impacted by unexpected market conditions.
This aggregate rating is based on analysts' research of Establishment Labs Holdings Inc and is not a guaranteed prediction by Public.com or investment advice.
ESTA Analyst Forecast & Price Prediction
Start investing in ESTA
Order type
Buy in
Order amount
Est. shares
0 shares